Medical Research News and Research

RSS

Alternatives to cigarette smoking may still pose a risk to human health due to over-use

Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.

29 Aug 2014

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.

29 Aug 2014

NIH to start initial human testing of investigational Ebola vaccine next week

Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

29 Aug 2014

New biomarker may improve diagnosis of early-stage rheumatoid arthritis

A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology.

From Quest Diagnostics 28 Aug 2014

Continuous positive airway pressure treatment effective for older patients with OSA

Continuous positive airway pressure is effective at treating sleep apnoea in older people, a new study has found.

27 Aug 2014

TxCell announces five new patents for core technology and ASTrIA platform

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, today announces that five new patents for their technologies have been issued in the Unites States, Asia and Australia since the beginning of 2014.

27 Aug 2014

Dr. John S. Sampalis nominated as finalist in the 2014 EY Entrepreneur Of The Year award

Dr. John S. Sampalis is founder and CEO of JSS Medical Research and one of the world's leading clinical epidemiologists. Dr. Sampalis is nominated as a finalist in this year's 2014 EY Entrepreneur Of The Year in the Québec Health Sciences category.

22 Aug 2014

New gene therapy protects mice from life-threatening heart condition

A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.

21 Aug 2014

OMRF receives $14.5 million grant from NIH to continue research on anthrax

The National Institutes of Health has awarded the Oklahoma Medical Research Foundation a five-year, $14.5 million grant to continue its research on anthrax and the bacteria's effects on humans.

21 Aug 2014

New antibodies could pave way for more effective drugs to combat influenza infection

Research toward developing new antibodies at the Hebrew University of Jerusalem's Faculty of Medicine could pave the way for more effective drugs to combat influenza infection.

20 Aug 2014

Acetyl fentanyl is more potent and dangerous than heroin

Emergency physicians should expect "an upswing in what on the surface appear to be heroin overdoses," but are actually overdoses tied to acetyl fentanyl, an opiate that is mixed into street drugs marketed as heroin.

19 Aug 2014

Penn researchers analyze clinical practice guidelines

The common thought in the medical community is that the randomized, controlled trial is the gold standard in medical research.

19 Aug 2014

Researchers validate criteria that predicts early menopause in young cancer survivors

Girls with cancer who are most likely to become infertile after treatment can be identified using guidelines developed almost 20 years ago, new research shows.

19 Aug 2014

Study shows bryostatin plays key role in slowing or reversing Alzheimer's disease

Neurotrope, Inc. (OTCQB: NTRP) today announced that results from a new study, entitled, "PKCe Deficits in Alzheimer's Disease Brains and Skin Fibroblasts," published in the recent edition of the peer-reviewed Journal of Alzheimer's Disease and co-authored by Tapan K. Khan, Ph.D.; Abhik Sen, Ph.D.; Jarin Hongpaisan, Ph.D.; Chol S. Lim, Ph.D.; Thomas J. Nelson, Ph.D., and; Dr. Daniel L. Alkon, each of the Blanchette Rockefeller Neurosciences Institute (BRNI), provide further indication of the role that protein kinase C epsilon (PKCe) may play in the potential treatment of Alzheimer's disease (AD).

19 Aug 2014

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.

19 Aug 2014

Neo40 nitric oxide supplement helps promote normal blood pressure

Nitric oxide supplementation using a Neo40 lozenge significantly helps promote normal blood pressure, as indicated by a 30-day, blinded, placebo-controlled clinical study, conducted at the California Medical Institute by renowned cardiology researcher Dr. Ernst Schwarz.

18 Aug 2014

Doctor provides advice on how best to prepare children with diabetes to go back to school

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25 years of experience treating pediatric patients with diabetes.

18 Aug 2014

Study sheds new light on how carbon monoxide could help protect hearts against arrhythmias

A study, funded by the British Heart Foundation and Medical Research Council, has shed new light on how carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack.

16 Aug 2014

University of Alaska Fairbanks receives $18.8M from NIH for biomedical research

The University of Alaska Fairbanks received an $18.8 million award from the National Institutes of Health to fund statewide biomedical research and student training focused on the interface of health, disease and the environment in people and animals.

14 Aug 2014

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.

13 Aug 2014

Medical Research News and Research

Alternatives to cigarette smoking may still pose a risk to human health due to over-use

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

NIH to start initial human testing of investigational Ebola vaccine next week

New biomarker may improve diagnosis of early-stage rheumatoid arthritis

Continuous positive airway pressure treatment effective for older patients with OSA

TxCell announces five new patents for core technology and ASTrIA platform

Dr. John S. Sampalis nominated as finalist in the 2014 EY Entrepreneur Of The Year award

New gene therapy protects mice from life-threatening heart condition

OMRF receives $14.5 million grant from NIH to continue research on anthrax

New antibodies could pave way for more effective drugs to combat influenza infection

Acetyl fentanyl is more potent and dangerous than heroin

Penn researchers analyze clinical practice guidelines

Researchers validate criteria that predicts early menopause in young cancer survivors

Study shows bryostatin plays key role in slowing or reversing Alzheimer's disease

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

Neo40 nitric oxide supplement helps promote normal blood pressure

Doctor provides advice on how best to prepare children with diabetes to go back to school

Study sheds new light on how carbon monoxide could help protect hearts against arrhythmias

University of Alaska Fairbanks receives $18.8M from NIH for biomedical research

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News